Abemaciclib for treating patients with HR+/HER2-metastatic breast cancer: a real-world study in France, Italy and Spain

Artículo original

Año: 2024

Blancas, I; Grosjean, J; Pedersini, R; Buzzoni, C; Sleilaty, G; Molero, A; Tamma, A; Chouaki, N; Atienza, M; Emde, A; Siddi, S; Bayona, RS; Del Mastro, L; Fakhouri, W

Título: FUTURE ONCOLOGY

• Q2